Selank
A synthetic heptapeptide analogue of the endogenous immunomodulatory peptide tuftsin. Selank exhibits anxiolytic properties in animal models via serotonergic and dopaminergic pathways, with additional research demonstrating memory enhancement and BDNF upregulation without sedation or dependence.
Research Use Only. Selank is sold exclusively for in vitro research and laboratory use by qualified scientists. Not for human consumption, veterinary use, or clinical administration.
Research Literature
Published Research
Selank is a tuftsin-derived anxiolytic heptapeptide with serotonergic and dopaminergic activity, studied for anxiety, memory enhancement, and BDNF upregulation.
Selank anxiolytic effects in preclinical models
Key finding: Selank produces robust anxiolytic effects comparable to benzodiazepines without sedation, dependence, or tolerance.
PubMed 22693035 ↗Selank and BDNF expression in brain tissue
Key finding: Selank administration significantly upregulated BDNF and TrkB expression in hippocampal and cortical regions.
PubMed 24793550 ↗Nootropic and neuroprotective properties of Selank
Key finding: Memory consolidation improvements and serotonin system modulation without dependency markers confirmed in long-term studies.
PubMed 27418085 ↗Same Category